Orpea SA (OPA1) Price & Analysis
OPA1 Stock Chart & Stats
- Day’s Range
- EUR 9.90 - EUR 10.48
- 52-Week Range
- EUR 9.58 - EUR 15.45
- Previous Close
- EUR 11.42
- Volume
- 0
- Average Volume (3M)
- 120
- Market Cap
- EUR 1.61B
- Enterprise Value
- EUR 10.44B
- Total Cash (Recent Filing)
- EUR 337.00M
- Total Debt (Recent Filing)
- EUR 8.02B
- Price to Earnings (P/E)
- ―
- Beta
- 0.76
- Next Earnings
- May 07, 2027
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
Bulls Say, Bears Say
Bulls Say
Revenue And Occupancy Growth
Organic revenue growth combined with higher occupancy indicates improving utilization of the care network and stronger demand capture. Sustained occupancy above 90% can support recurring accommodation and care revenue, while pricing momentum may help preserve growth across the next several quarters.
Margin Expansion
Strong EBITDA growth and wider margins show that operational recovery is translating into improved earnings before financing costs. If productivity and occupancy gains persist, the higher margin base can strengthen internal cash generation and create greater capacity to address the company’s financial obligations.
Operational Recovery And Guidance
The guidance upgrade and Boost efficiency program provide a defined path for continued operating improvement rather than relying solely on market growth. Planned recurring cost reductions across pharmacies, laundry and equipment could support margin durability and reinforce management’s medium-term recovery objectives.
Bears Say
High Leverage
Leverage has improved materially but remains high relative to operating earnings, leaving the company dependent on continued deleveraging and execution. The debt burden limits financial flexibility, increases sensitivity to operating setbacks and can constrain investment while the business works toward its covenant objective.
Loss-Making Results
The substantial improvement in net income is encouraging, but the company has not yet reached sustainable profitability. Continued losses reduce retained capital and make the recovery more dependent on operational gains, cost control and lower financing pressure before earnings can become consistently durable.
Cash Conversion Pressure
Positive operating cash flow is being offset by normalization payments and higher maintenance investment, limiting the cash available for debt reduction. Although some outflows are nonrecurring, rising capital needs and ongoing cash conversion tasks could slow deleveraging and restrict liquidity flexibility over the medium term.
OPA1 FAQ
What was Orpea SA’s price range in the past 12 months?
What is Orpea SA’s market cap?
When is Orpea SA’s upcoming earnings report date?
How were Orpea SA’s earnings last quarter?
Is Orpea SA overvalued?
Does Orpea SA pay dividends?
What is Orpea SA’s EPS estimate?
How many shares outstanding does Orpea SA have?
What happened to Orpea SA’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Orpea SA?
What is the TipRanks Smart Score and how is it calculated?
Company Description
Orpea SA
Emeis Société anonyme operates as a prominent provider of diverse healthcare services, encompassing the management of nursing homes, assisted-living facilities, specialized post-acute and rehabilitation hospitals, and psychiatric treatment centers. Within its elderly care residences, the company delivers tailored support alongside comprehensive logistical and residential amenities, including comfortable accommodation, meal services, laundry, and room maintenance. These facilities also enrich residents' lives with a variety of daily events, recreational activities, and therapeutic workshops. Emeis's post-acute and rehabilitation hospitals are equipped to treat a wide array of medical conditions, such as geriatric issues, musculoskeletal and neurological disorders, cardiovascular and hematological ailments, oncology recovery, and care for individuals in persistent vegetative or minimally conscious states. The psychiatric hospitals address an extensive spectrum of mental health concerns, ranging from mood, anxiety, and obsessive-compulsive disorders to addictions, eating disorders, sleep disturbances, personality disorders, age-related psychiatric conditions, psychosis, and stress-induced conditions like burnout, chronic fatigue syndrome, fibromyalgia, psychosomatic issues, and post-traumatic stress disorder. Furthermore, they offer specialized psychiatric care for geriatrics, children, young adults, and parent-child dynamics, serving both public and private patients. Complementing its institutional offerings, Emeis also provides comprehensive home care solutions. These include practical domestic assistance such as cleaning, meal preparation, ironing, gardening, and running errands; daily living support encompassing day or night supervision and aid with hygiene and meals; and mobility assistance. Founded in 1989 and headquartered in Puteaux, France, the company maintains an expansive international presence, with operations spanning numerous countries across Europe, Latin America, and Asia, including France, Belgium, Spain, Italy, Ireland, Switzerland, Austria, Germany, the Czech Republic, Poland, the Netherlands, Luxembourg, Portugal, Brazil, Russia, Slovenia, Uruguay, Colombia, Mexico, Chile, Latvia, Croatia, and China.
- Sector
- General
- Industry
- Medical - Care Facilities
- CEO
- Laurent Guillot
- Employees
- 84,600
- Website
- www.emeis.com
- Address
- 12, rue Jean-JaurEs, Puteaux, IDF, 92813, FR
Orpea SA (OPA1) Earnings & Revenues
OPA1 Earnings Call
Earnings Call SentimentPositive
The call conveyed a clear recovery trajectory: strong organic revenue growth (6%), meaningful occupancy gains (+~2.8 pts), significant margin expansion and large improvements in leverage (net debt reduced by ~EUR 566m and leverage down to 8.7x). Management upgraded FY guidance and outlined a credible operational program (Boost) that should drive further OpEx reductions. Offsetting these positives are remaining structural issues: the group is still reporting a negative net result (EUR -40m), cash flow was hit by one-off normalization items (working capital + EUR 94m and nonrecurring settlements ~EUR 164m), maintenance CapEx and inflation pose medium-term pressures, and net debt remains substantial. Overall, positives (revenue/margin improvement, guidance upgrade, balance sheet progress and operational levers) materially outweigh the lowlights, but the company still faces important operational and cash conversion tasks to fully normalize profitability and reduce leverage to covenant levels.
View all DE:OPA1 earnings summariesTechnical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 11 | 4 | 6 |
| Technical Analysis | 3 | 4 | 2 |
| Moving Averages | 8 | 0 | 4 |